Investor Day Japan Fall 2026
[Last Updated: Nov 2 JST]
iCONM in collaboration with BioLabs、アステラス製薬株式会社、一般社団法人LINK-J、および米国BioLabsの4社共催により、Investor Day Japan Fall 2026を開催いたします。今年3月に開催し、大変ご好評をいただいた「Investor Day Japan Spring 2026」に続く第2回目の開催となります。
本イベントでは、日本のBioLabs Friendsが集結し、BioLabsのグローバルネットワークとともに、アーリーミドル期の創薬スタートアップが自らの創薬ストーリーを国内外の投資家・創薬専門家に発信する場を提供いたします。参加スタートアップが本イベントを通じて新たなビジネスチャンスを掴み、創薬事業の成長を加速させることを目指します。選出された8社によるピッチプレゼンテーションに加え、グローバルに活躍するライフサイエンス投資家7名を迎え、日本のバイオテック企業が世界の投資家から評価されるために必要な要素を議論するパネルディスカッションを実施します。
iCONM in collaboration with BioLabs, Astellas Pharma Inc., LINK-J, and BioLabs Global (U.S.) will co-host Investor Day Japan Fall 2026. Following the tremendous success of Investor Day Japan Spring 2026, held this past March, this event marks the second edition of the Investor Day Japan series.
This event brings together the BioLabs Friends in Japan and the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts from Japan and around the world. Through this event, we aim to help participating startups seize new business opportunities and accelerate the growth of their drug discovery ventures. The program features pitches from eight selected biotech startups, followed by a panel discussion with seven global life science investors exploring what it takes to build globally investable biotech companies in Japan.
==
🚀 Meet the 8 Finalists
Materia Therapeutics KK
LoopLab Bio
Apotek Biotechnologies Inc.
University of Shizuoka
Curogen
HiLung Inc.
Surzen Biotherapeutics
Crafton Biotechnology Co., Ltd.
🦅 Meet Our Investor Judges & Panelists
We are delighted to welcome seven distinguished investors and industry leaders, who will serve as judges for the startup pitches and panelists for our featured discussion.
Aiden Aceves | Vice President, Insight Partners
Andrew Levin | Investor, Entrepreneur
Anja König | Global Head of NVF, Novartis Venture Fund
Jeff Goater | Partner, The Column Group (TCG)
Kelly Qiao | Senior Principal, B Capital
Ken Horne | Managing Partner, ANV
Nandita Shangari | Managing Director, RA Capital
日時 / Date：Nov 11, 2026
会場 / Venue：日本橋ライフサイエンスビルディング201（東京都中央区日本橋本町2-3-11）/ Nihonbashi Life Science Building 201, Tokyo
開催形式 / Format：
Startup Pitch Presentations: ハイブリッド / Hybrid
Panel Discussion & Networking Reception: 現地開催 / On-site only
Agenda
8:30 AM – 10:15 AM JST | HYBRID
Startup Pitch Presentations (5-minute pitch + 5-minute Q&A)
Hear live feedback from investors while enjoying coffee and pastries!
10:30 AM – 11:15 AM JST | ON-SITE
Panel Discussion
What Makes a Japanese Biotech Globally Investable?
Join our seven investor judges for an interactive conversation on what global life science investors look for in emerging biotech companies!
11:30 AM – 1:00 PM JST | ON-SITE
Networking Event over Lunch (Lunch will be provided!)
⚠️ Registration Notes:
We recommend registering with your company or institutional email address rather than a personal account.
ご登録の際は、会社・所属機関のメールアドレスのご使用を推奨いたします。All registrations are subject to review by the organizing team. To ensure a smooth and secure event, we reserve the right to change in-person registrations to online participation at our discretion.
円滑かつ安全なプログラム運営のため、運営チームにてお申し込み内容を確認し、必要に応じて現地参加からオンライン参加へ変更させていただく場合がございます。Please note that online registration does not grant access to the on-site event.
オンライン参加でお申し込みいただいた方は、原則として当日の現地参加はできません。